D-1359-2016 Class II Terminated

Recalled by Hospira Inc. — Lake Forest, IL

FDA drug recall D-1359-2016 was initiated by Hospira Inc. on Jun 23, 2016 and is designated Class II. Reason for recall: Crystallization: Product contains particulate identified to be crystallized active ingredient. The recall status is terminated (terminated Aug 31, 2018). Affected quantity: 373,850 tubes.

Recall details

Product Type
Drugs
Report Date
Jul 20, 2016
Initiation Date
Jun 23, 2016
Termination Date
Aug 31, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
373,850 tubes

Product description

Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc. Lake Forest, IL 60045, NDC 0409-1273-32

Reason for recall

Crystallization: Product contains particulate identified to be crystallized active ingredient.

Distribution pattern

Nationwide

Code information

Lot #: 52610LL, Exp. 01 OCT 2016; Lot #: 57660LL, Exp. 01 MAR 2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1359-2016
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Hospira Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-1359-2016. Report a data issue: hello@regdatalab.com.